Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Iradimed Corp (IRMD)
NASDAQ:IRMD
Holding IRMD?
Track your performance easily
Earnings Data
Report Date
Feb 06, 2025TBA Not Confirmed
Period Ending
2024 (Q4)Consensus EPS Forecast
$0.44Last Year’s EPS
$0.39Same Quarter Last Year
Moderate Buy
Based on 1 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Oct 31, 2024
|% Change Since: 3.52%
|Next Earnings Date:Feb 06, 2025
Earnings Call Sentiment|Positive
The earnings call reflects a strong performance with record revenue and growth, high gross profit margins, and increased earnings guidance. However, there are challenges with rising operating expenses and a potential temporary dip in pump revenue during the transition to a new product. Overall, the positive aspects of record growth and strong financial performance outweigh the challenges.Company Guidance
In the third quarter 2024 earnings call for IRadimed Corporation, CEO Roger Susi announced record revenue growth, marking the company's 13th consecutive record quarter with revenue reaching $18.3 million, up from $17.9 million in the previous quarter. The company maintained a gross profit margin of 77.4% and achieved earnings of $0.40 per diluted share. For the fourth quarter, IRadimed provided guidance with expected revenue between $18.8 million to $19.2 million, GAAP diluted earnings per share of $0.39 to $0.42, and non-GAAP diluted earnings per share of $0.42 to $0.45. The annual revenue target was revised to $72.7 million to $73.1 million, with an upgraded forecast for GAAP diluted earnings per share to $1.49 to $1.52 and non-GAAP diluted earnings per share to $1.64 to $1.67, reflecting the company's continued robust performance and strategic initiatives.Record 13th Consecutive Quarter
IRadimed reported its 13th consecutive record quarter with revenue reaching $18.3 million, up from $17.9 million in the previous quarter.
Strong Revenue Growth
Revenue for the third quarter of 2024 was $18.3 million, an increase of 11% compared to the third quarter of 2023. Domestic sales increased 9% and international sales increased 22%.
High Gross Profit Margin
Gross profit remained high at 77.4%.
Increased Earnings Guidance
The company raised its guidance for GAAP diluted earnings per share for the year to $1.49 to $1.52 from the previous guidance of $1.37 to $1.47.
Strong Cash Flow
Cash from operations was strong at $9.1 million for the three months ended September 30, 2024, up from $1.4 million for the same period in 2023.
---
IRMD Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
IRMD Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Oct 31, 2024 | $52.79 | $49.13 | -6.93% |
| Aug 01, 2024 | $46.42 | $45.87 | -1.18% |
| May 02, 2024 | $41.60 | $43.43 | +4.40% |
| Feb 08, 2024 | $46.08 | $46.10 | +0.04% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Iradimed Corp (IRMD) report earnings?
Iradimed Corp (IRMD) is schdueled to report earning on Feb 06, 2025, TBA Not Confirmed.
What is Iradimed Corp (IRMD) earnings time?
Iradimed Corp (IRMD) earnings time is at Feb 06, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is IRMD EPS forecast?
IRMD EPS forecast for the fiscal quarter 2024 (Q4) is $0.44.
---